Clovis Oncology, Inc.
CLVSDelisted Dec 29, 2022- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001466301
Clovis Oncology, Inc. was delisted on Dec 29, 2022; its insiders filed their last Form 4 on Nov 3, 2022; 103 institutions reported holding it in 13F filings for Q3 2022, worth $42.6M in total; no superinvestor held it.
Q1 2023 vs. Q4 2022
How the institutions holding Clovis Oncology, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 15 | 2 | −13 |
| Shares | 400.6K | 36.8K | −363.8K (−90.8%) |
| Value | $20.1K | $520.2K | +$500.1K (+2,491.8%) |
New holders (0)
Institutions that held Clovis Oncology, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
None.
Sold out (13)
Institutions that held Clovis Oncology, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Macquarie Group Ltd | 250,200 | $13.0K |
| S&T Bank | 60,000 | $3.00K |
| Wedbush Securities Inc | 20,200 | $1.00K |
| Future Financial Wealth Managment LLC | 13,500 | $712 |
| Newbridge Financial Services Group, Inc. | 12,500 | $659 |
| Qube Research & Technologies Ltd | 11,980 | $632 |
| Quent Capital, LLC | 231 | $12 |
| Tower Research Capital LLC (TRC) | 660 | $0 |
| Rockefeller Capital Management L.P. | 375 | $0 |
| Kozak & Associates, Inc. | 140 | $0 |
| IFP Advisors, Inc | 10,050 | – |
| Coppell Advisory Solutions LLC | 265 | – |
| Coppell Advisory Solutions Corp. | 265 | – |